Circulating lncRNA BC030099 Increases in Preeclampsia Patients

Area of Science:

• Molecular Biology
• Biomarker Discovery
• Reproductive Medicine

Background:

• Long noncoding RNAs (lncRNAs) are key regulators in various diseases.
• Circulating lncRNAs are emerging as valuable diagnostic biomarkers.
• Preeclampsia diagnosis can benefit from novel biomarker identification.

Purpose of the Study:

• To investigate circulating lncRNAs as potential diagnostic biomarkers for preeclampsia.
• To evaluate the expression of specific uterine-related lncRNAs in preeclampsia patients.

Main Methods:

• Quantitative reverse transcription PCR (qRT-PCR) was used to measure lncRNA expression.
• Whole blood samples were collected from 48 preeclampsia patients and 24 healthy controls.
• Receiver operating characteristic (ROC) curve analysis was performed.

Main Results:

• Circulating lncRNA BC030099 levels were significantly higher in preeclampsia patients compared to controls (p < 0.05).
• The ROC curve analysis for lncRNA BC030099 yielded an area under the curve of 0.713.
• lncRNA BC030099 was identified as an independent predictor of preeclampsia.

Conclusions:

• Increased plasma levels of lncRNA BC030099 are associated with preeclampsia.
• lncRNA BC030099 shows potential as a novel diagnostic biomarker for preeclampsia.